Why the study?
Does carotid intima-media thickness (CIMT) measurement improve cardiovascular risk prediction and guide preventive therapy?
Does carotid intima-media thickness (CIMT) measurement improve cardiovascular risk prediction and guide preventive therapy?
Answers are grounded in this paper and cite their sources.
CIMT is a noninvasive and reproducible screening tool that can refine cardiovascular risk prediction and help guide preventive strategies.
Cardiovascular risk factors have utility in risk prediction but have limitations in predicting individual risk. Identifying an individual's risk remains a challenge. Emerging technologies such as carotid artery ultrasonography and measures of carotid intima-media thickness (CIMT) may be useful in identifying the susceptible patient who may benefit from more aggressive preventive therapy. This screening test is noninvasive, reproducible, inexpensive, and radiation-free. Recent data have improved our understanding of the application of CIMT as a screening tool for cardiovascular disease. CIMT measurement may place an individual into a higher- or lower-risk category, allowing for appropriate institution of preventive strategies.
No takes yet. Share an insight, caveat, or question.
Mookadam et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: